作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers:
ChemoCentryx (NASDAQ:CCXI) +95%
Voyager Therapeutics (NASDAQ:VYGR) +44%
ReShape Lifesciences (NASDAQ:RSLS) +26%
Flora Growth (NASDAQ:FLGC) +6%
Sundial Growers (NASDAQ:SNDL) +5%
Losers:
Allogene Therapeutics (NASDAQ:ALLO) -46%
Nkarta (NASDAQ:NKTX) -27%
Cellectis (NASDAQ:CLLS) -24%
Caribou Biosciences (NASDAQ:CRBU) -15%
Omeros (NASDAQ:OMER) -9%
蹊之美股生物医药 / CaesarBiotech
追踪和剖析全球最前沿生物科技公司，寻找低估值/革命性的生物科技产品或技术平台，深入挖掘其投资价值。
联系方式：CaesarBiotech@aliyun.com
本文首发：蹊之美股生物医药
版权声明
本文原创，如需转载请联系授权